Bullous pemphigoid in India: Review of cases registered in an autoimmune bullous disease clinic
Indian Journal of Dermatology, Venereology and Leprology · 2022
DOI: 10.25259/ijdvl_1417_20 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2022. Verfasst von Dipankar De und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Diabetes Mellitus, Type 2, Autoimmune Diseases, Skin Diseases, Vesiculobullous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background
Information on bullous pemphigoid in an Indian context is scarce.
Aim
To report clinico-demographic profile, associated comorbidities and prescription pattern of bullous pemphigoid patients in India.
Methods
This was a retrospective study, where past records of all bullous pemphigoid patients diagnosed and treated between November 2013 and October 2019 were accessed and analysed. Patients having a compatible clinical presentation with either histopathological and/or direct immunofluorescence evidence of bullous pemphigoid were included.
Results
There were 96 bullous pemphigoid patients, with a male: female ratio of 1.6:1. The mean age at diagnosis was 62.5 ± 2.2 years, with mean duration of illness 27.5 ± 4.5 months before presentation. Comorbidities were present in 80 (83%) patients, with type 2 diabetes mellitus (38.5%), hypertension (36.4%) and neurological illness (16.7%) being the commonest ones. Clinically, blisters were the predominant presentation in 81 (84.4%) patients. The majority (87.5%) of patients showed a predominant eosinophilic infiltrate on histopathology. Direct immunofluorescence revealed immunoglobulin G deposits with complement C3 in 77 (80.2%) cases. The majority of patients (77.1%) were treated with oral prednisolone, either alone (11.5%) or in combination (65.6%) with other topical and systemic agents. Topical steroids were used in 29.1%, azathioprine in 28%, dapsone in 16.7% and omalizumab in 6.2% of patients.
Limitations
The study is retrospective. Immunofluorescence on salt split skin, direct immunofluorescence serration pattern analysis, and immunoblotting were not performed. Hence, there is a possibility that a few included cases were suffering from other subepidermal autoimmune bullous diseases like epidermolysis bullosa acquisita or anti-p200 pemphigoid.
Conclusion
Bullous pemphigoid patients in this study had a younger age of onset and showed male preponderance. Comorbidities like type 2 diabetes, hypertension and neurological disorders were frequent. Cutaneous blisters were the most frequent clinical presentation. Systemic corticosteroids comprised the mainstay of therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
- Department of Histopathology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
- Department of Immunopathology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Zitieren
APA
De, D., Kaushik, A., Handa, S., Mahajan, R., Chatterjee, D., Saikia, B., Saikia, U. N., Radotra, B. D., & Minz, R. W. (2022). Bullous pemphigoid in India: Review of cases registered in an autoimmune bullous disease clinic. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_1417_20
Vancouver
De D, Kaushik A, Handa S, Mahajan R, Chatterjee D, Saikia B, et al. Bullous pemphigoid in India: Review of cases registered in an autoimmune bullous disease clinic. Indian Journal of Dermatology, Venereology and Leprology. 2022. doi:10.25259/ijdvl_1417_20
BibTeX
@article{De2022,
author = {De, Dipankar and Kaushik, Akanksha and Handa, Sanjeev and Mahajan, Rahul and Chatterjee, Debajyoti and Saikia, Biman and Saikia, Uma Nahar and Radotra, Bishan Dass and Minz, Ranjana W},
title = {Bullous pemphigoid in India: Review of cases registered in an autoimmune bullous disease clinic},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2022},
doi = {10.25259/ijdvl_1417_20}
}
EUVIMED